
Paradromics Inc Profile last edited on: 9/23/2021
CAGE: 7DYU3
UEI: MD3CFK6J7ZQ4
Business Identifier: Brain-machine interfacing technology: increase data transmission rate between brains and machines Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
4030 West Braker Lane Suite 250
Austin, CA 78759
Austin, CA 78759
(408) 208-0500 |
info@paradromics.com |
www.paradromics.com |
Location: Single
Congr. District: 10
County: Travis
Congr. District: 10
County: Travis
Public Profile
Paradromics is developing next-generation brain-machine interfaces designed majorly to increase the data transmission rate between brains and computers. The plan is to enable neural interface technologies initially to be used to enable physically disabled patients to reconnect with the outside world. Massively Parallel Neural Interfaces and RealTime Decoding will enable better treatment options for neurodegenerative diseases and advanced neuroprosthetic limbs for those suffering from amputation or spinal cord injuries. Describing themselves as developing high-bandwidth Neural Interfaces for advanced prosthetic therapies, almost coincident with converting their first SBIR (in NIH) from Phase I to Phase II, the firm was awarded one of SIX high profile DARPA Awards - that of Paradromics values at $18.6M - to work on Brain Computer interface potentially having important impact in provding better treatment options for neurodegenerative diseases and advanced neuroprosthetic limbs for those suffering from amputation or spinal cord injuries.. Remarkable!
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
25-49Revenue Range
2.5M-5MVC funded?
YesPublic/Private
Privately HeldStock Info
----IP Holdings
5-9Awards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2023 | 2 | NIH | $3,156,162 | |
Project Title: Development and evaluation of novel high-density intracortical microelectrode arrays for clinical applications | ||||
2017 | 2 | NIH | $797,771 | |
Project Title: Commercial development of microwire bundle technology for massively parallel neural recording. |
Key People / Management
Matthew R Angle -- Founder and CEO
Jennifer Beardsall -- Mechanical and Process Engineer
James Burrows -- Chief Operating Officer
John Horn -- Counsel
Edmund Huber -- Founder and CIO
Adam Kablanian -- Chairman Of The Board
Aamir Khan -- Electrical Engineer
Yifan Kong -- Chief Technology Officer
Chris Larau -- Senior Software Engineer
Matt Marino -- VP of Finance
Nicholas A Melosh
Daniel Pouzzner -- Senior Software Engineer
Kunal Sahasrabuddhe -- Applied Scientist & Director of Systems Integration
Andreas Schaefer -- President
Aleksandar Tadic -- Senior Product Development Engineer
Jennifer Beardsall -- Mechanical and Process Engineer
James Burrows -- Chief Operating Officer
John Horn -- Counsel
Edmund Huber -- Founder and CIO
Adam Kablanian -- Chairman Of The Board
Aamir Khan -- Electrical Engineer
Yifan Kong -- Chief Technology Officer
Chris Larau -- Senior Software Engineer
Matt Marino -- VP of Finance
Nicholas A Melosh
Daniel Pouzzner -- Senior Software Engineer
Kunal Sahasrabuddhe -- Applied Scientist & Director of Systems Integration
Andreas Schaefer -- President
Aleksandar Tadic -- Senior Product Development Engineer